Back to the main directory
Press Release
- C&F Financial Corporation Announces Quarterly Dividend by GlobeNewsWire
- Holiday Savings Surge: Oportun Reports $6.5 Million Saved for 2025, Up 30% From 2024 by GlobeNewsWire
- Novartis announces plans to build flagship manufacturing hub in North Carolina by GlobeNewsWire
- Logansport Financial Corp. Announces Fourth Quarter Dividend by GlobeNewsWire
- Canacol Energy Granted Creditor Protection to Pursue Restructuring by GlobeNewsWire
- Protext Mobility, Inc. (OTC: TXTM) Provides Shareholder Update by GlobeNewsWire
- THEON Invited by OCCAR to Sign Contract Revision by GlobeNewsWire
- Weekly share repurchase program transaction details by GlobeNewsWire
- Rapala VMC Corporation Issues EUR 25 Million Hybrid Bond by GlobeNewsWire
- Kitron Acquires DeltaNordic, Strengthening Its Position in Defence by GlobeNewsWire
- Toll Brothers Opens Willows at Brookfield Luxury Townhome Community in Brookfield, Connecticut by GlobeNewsWire
- PIEDMONT REALTY TRUST ANNOUNCES PRICING OF CASH TENDER OFFER FOR ANY AND ALL OF ITS OUTSTANDING 9.250% SENIOR NOTES DUE 2028 by GlobeNewsWire
- MULTIMEDIA UPDATE - Holiday Savings Surge: Oportun Reports $6.5 Million Saved for 2025, Up 30% From 2024 by GlobeNewsWire
- BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) by GlobeNewsWire
- Five Below, Inc. Announces Third Quarter 2025 Earnings Release and Conference Call Date by GlobeNewsWire
- Capital Southwest Announces Monthly Regular Dividends for the Quarter Ending March 31, 2026 and Quarterly Supplemental Dividend Payable on March 31, 2026 by GlobeNewsWire
- Pyxis Tankers Announces Date for the Release of the Third Quarter 2025 Results by GlobeNewsWire
- Safe Bulkers, Inc. Sets Date for the Third Quarter 2025 Results, Conference Call, and Webcast by GlobeNewsWire
- OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference by GlobeNewsWire
- ODDITY Tech Reports Record Third Quarter Results, Raises Full Year Outlook by GlobeNewsWire
- Upwork to Present at UBS Global Technology and AI Conference by GlobeNewsWire
- EYLEA HD® (aflibercept) Injection 8 mg Approved by FDA for the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing Across Approved Indications by GlobeNewsWire
- ACCO GROUP HOLDINGS LIMITED ANNOUNCES PARTIAL EXERCISE OF UNDERWRITERS’ OVER-ALLOTMENT OPTION by GlobeNewsWire
- ZyVersa Therapeutics Reports Third Quarter 2025 Financial Results by GlobeNewsWire
- PRIMEENERGY RESOURCES CORPORATION (PNRG) ANNOUNCES THIRD QUARTER RESULTS by GlobeNewsWire